Intracranial Myxoid Mesenchymal Tumour with EWSR1-ATF1 Fusion Sans Myxoid Stroma - Report of A Newer Entity with Brief Review of Literature.
暂无分享,去创建一个
[1] G. Reifenberger,et al. The 2021 WHO Classification of Tumors of the Central Nervous System: a summary. , 2021, Neuro-oncology.
[2] D. Tran,et al. Intracranial myxoid mesenchymal neoplasms with EWSR1 gene rearrangement: report of 2 midline cases with one demonstrating durable response to MET inhibitor monotherapy , 2021, Neuro-oncology advances.
[3] J. Liu,et al. Adult intracranial myxoid mesenchymal tumor with EWSR1-ATF1 gene fusion. , 2020, World neurosurgery.
[4] Jorge Lima,et al. Myxoid mesenchymal intraventricular brain tumour with EWSR1–CREB1 gene fusion in an adult woman , 2020, Virchows Archiv.
[5] G. Fuller,et al. Intracranial Myxoid Mesenchymal Tumor With EWSR1-ATF1 Fusion. , 2020, Journal of neuropathology and experimental neurology.
[6] Thomas M Pearce,et al. Intracranial Myxoid Mesenchymal Tumor with Rare EWSR1-CREM Translocation , 2019, Pediatric Neurosurgery.
[7] R. Sciot,et al. Primary myxoid mesenchymal tumour with intracranial location: report of a case with a EWSR1–ATF1 fusion , 2018, Histopathology.
[8] K. Ligon,et al. Intracranial myxoid mesenchymal tumors with EWSR1–CREB family gene fusions: myxoid variant of angiomatoid fibrous histiocytoma or novel entity? , 2018, Brain pathology.
[9] C. Antonescu,et al. EWSR1 Fusions With CREB Family Transcription Factors Define a Novel Myxoid Mesenchymal Tumor With Predilection for Intracranial Location , 2017, The American journal of surgical pathology.
[10] T. Strojnik,et al. Prognostic value of erythrocyte sedimentation rate and C-reactive protein in the blood of patients with glioma. , 2014, Anticancer research.